1-3 of 3
Fernando Concha-Benavente
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients

Fernando Concha-Benavente, Benjamin Kansy, Jessica Moskovitz, Jennifer Moy, Uma Chandran, Robert L. Ferris
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (12): 1548–1560.
https://doi.org/10.1158/2326-6066.CIR-18-0062
Published: 03 December 2018
View article titled, PD-L1 Mediates Dysfunction in Activated PD-1<sup>+</sup> NK Cells in Head and Neck Cancer Patients
Open the PDF for PD-L1 Mediates Dysfunction in Activated PD-1<sup>+</sup> NK Cells in Head and Neck Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice

Andrea Sobo-Vujanovic, Lazar Vujanovic, Albert B. DeLeo, Fernando Concha-Benavente, Robert L. Ferris, Yan Lin, Nikola L. Vujanovic
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (5): 441–451.
https://doi.org/10.1158/2326-6066.CIR-15-0104
Published: 01 May 2016
View article titled, Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
Open the PDF for Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice in another window
Includes: Supplementary data
Journal Articles

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients

Raghvendra M. Srivastava, Sumita Trivedi, Fernando Concha-Benavente, Jie Hyun-bae, Lin Wang, Raja R. Seethala, Barton F. Branstetter, IV, Soldano Ferrone, Robert L. Ferris
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (8): 936–945.
https://doi.org/10.1158/2326-6066.CIR-15-0053
Published: 03 August 2015
View article titled, STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients
Open the PDF for STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients in another window
Includes: Supplementary data